Our mission is to extend the lives of patients with CNS-related disease.
Our opportunity is to utilize CSF for controlled, continuous, & personalized delivery to areas of the CNS most benefited by both existing & next-generation therapeutics.
Our strategy is two-fold:
1) Lead with neuro-oncology and help patients with Leptomeningeal Carcinomatosis.
2) Leveraging partnerships to expand into neurodegenerative, lysosomal storage & autoimmune diseases.